Lupin Launches “Authorized” Generic

[anonymous]

1. “Authorized” = Romark receives royalties $$$ or % of Lupin Generic Sales
2. Lupin stuffs the channel with cheaper generic $30-$40/tablet so wholesalers & pharmacies choose Lupin generic.
3. Representatives continue to promote short term to drive generic utilization.
4. Sales force makes “0” bonus.

Lupin Launches Authorized Generic Version of Alinia®

Mumbai, Baltimore, March 10, 2021: Global pharma major, Lupin Limited (Lupin), today announced the launch of the authorized generic version of Alinia® (nitazoxanide) Tablets, 500 mg of Romark Laboratories, L.C.

Nitazoxanide Tablets, 500 mg, are indicated in the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 years of age and older.

Nitazoxanide Tablets, 500 mg (RLD: Alinia®) had estimated annual sales of USD 56 million in the U.S. (IQVIA MAT January 2021).

 

[anonymous]

Finally, someone has done their homework and gets it!

 

[anonymous]

So, it’s finally happened. A generic for Romark’s sole,cproduct, Alinia, has come out and Romark is on the skids. Five years ago everyone saw this coming and Romark did nothing to boost its portfolio of one product. Instead it spent money it didn’t have to launch COVID trials it can’t pay for. In fact they can’t pay their rent and are being evicted.